In addition, the pronounced effect of CAT-1 down-regulation on CLL cell viability and tumor growth may partly be due to diminished uptake of the essential amino acid lysine that is also a CAT-1 substrate. Here, SLC7A1 is linked to B-cell chronic lymphocytic leukemia.